Identification and Validation of PCAT14 as Prognostic Biomarker in Prostate Cancer.
about
Long noncoding RNA PCAT-14 induces proliferation and invasion by hepatocellular carcinoma cells by inducing methylation of miR-372.RNAseq based transcriptomics study of SMCs from carotid atherosclerotic plaque: BMP2 and IDs proteins are crucial regulators of plaque stability.Long Non-Coding RNA as Potential Biomarker for Prostate Cancer: Is It Making a Difference?The Non-Coding Transcriptome of Prostate Cancer: Implications for Clinical Practice.Androgen receptor and miR-206 regulation in prostate cancer.The prognostic value of long noncoding RNAs in prostate cancer: a systematic review and meta-analysis.Long non-coding RNAs: new frontiers for advancing personalized cancer medicine in prostate cancer.Long non-coding RNA GAS5 and ZFAS1 are prognostic markers involved in translation targeted by miR-940 in prostate cancer.The prognostic value of abnormally expressed lncRNAs in prostatic carcinoma: A systematic review and meta-analysis.Cancer transcriptome profiling at the juncture of clinical translation.Crucial role of noncoding RNA in driving prostate cancer development and progression.High lncRNA HULC expression is associated with poor prognosis and promotes tumor progression by regulating epithelial-mesenchymal transition in prostate cancer.The use of long non-coding RNAs as prognostic biomarkers and therapeutic targets in prostate cancer.Pathological bases and clinical impact of long noncoding RNAs in prostate cancer: a new budding starCarcinogenesis in prostate cancer: The role of long non-coding RNAsA novel molecular mechanism for a long non-coding RNA PCAT92 implicated in prostate cancer
P2860
Q33798405-929CB0CB-98B9-4102-B250-471562120791Q33799171-5885BC5F-155E-4EC3-9D7F-1EFE2F3566AAQ37724539-D97198F1-31BC-4888-8FA8-CD18D68045E6Q38744451-927B59BF-B54D-4D6E-A907-1660AFD63E36Q38946793-9365CB03-6313-4A2F-8383-21214DA916ECQ41339824-015C091C-526C-42BE-B28C-8B791C05AE8CQ42353504-358120BA-EC05-4FEE-8810-5762333F402CQ49213554-BB0EB9A0-16E2-4F50-A6AC-F0AB48330905Q49486523-8EE910F4-B83C-41B8-8F9D-48F088BD365BQ49566680-77EB3375-9C6C-4701-9455-D824EB1FB28EQ52426413-50A372F8-AC17-40AB-9FCC-63D45BEC2C95Q55216970-0C27F56E-0DF9-47DC-AF66-C31E962B2138Q55356724-8CF02F30-3BC6-47DE-B680-46FBE079EC8EQ57109348-40F650BB-2AED-4333-AA0E-E72D92EB76D4Q57114753-CD4F74A8-CDDB-45D3-8809-1FDA461CDA4FQ58727464-A7DFB6B2-0506-4E1A-AE04-FDB7F40527DB
P2860
Identification and Validation of PCAT14 as Prognostic Biomarker in Prostate Cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Identification and Validation of PCAT14 as Prognostic Biomarker in Prostate Cancer.
@en
Identification and Validation of PCAT14 as Prognostic Biomarker in Prostate Cancer.
@nl
type
label
Identification and Validation of PCAT14 as Prognostic Biomarker in Prostate Cancer.
@en
Identification and Validation of PCAT14 as Prognostic Biomarker in Prostate Cancer.
@nl
prefLabel
Identification and Validation of PCAT14 as Prognostic Biomarker in Prostate Cancer.
@en
Identification and Validation of PCAT14 as Prognostic Biomarker in Prostate Cancer.
@nl
P2093
P2860
P1433
P1476
Identification and Validation of PCAT14 as Prognostic Biomarker in Prostate Cancer.
@en
P2093
Arul M Chinnaiyan
Ashley Ross
Bhavna Malik
Edward Schaeffer
Felix Y Feng
Huynh-Hoa Bui
Javed Siddiqui
Lanbo Xiao
Rohit Malik
Rohit Mehra
P2860
P304
P356
10.1016/J.NEO.2016.07.001
P577
2016-08-01T00:00:00Z